Avanos Medical, Inc. financial data

Symbol
AVNS on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
5405 Windward Parkway, Suite 100 South, Alpharetta, GA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Halyard Health, Inc. (to 6/28/2018)
Latest financial report
10-Q - Q2 2024 - Jul 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 239 % -21.9%
Quick Ratio 79.3 % -20.9%
Debt-to-equity 37.3 % +1.06%
Return On Equity 0.63 %
Return On Assets 0.46 %
Operating Margin 3.33 % +149%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.9M shares -1.97%
Common Stock, Shares, Outstanding 45.9M shares -1.96%
Entity Public Float 1.19B USD -6.83%
Common Stock, Value, Issued 500K USD 0%
Weighted Average Number of Shares Outstanding, Basic 45.9M shares -1.92%
Weighted Average Number of Shares Outstanding, Diluted 46.3M shares -1.07%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 682M USD +5.88%
Research and Development Expense 26.2M USD -6.76%
Operating Income (Loss) 22.7M USD +164%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 14M USD
Income Tax Expense (Benefit) 7M USD
Net Income (Loss) Attributable to Parent 7.7M USD
Earnings Per Share, Basic 0.17 USD/shares
Earnings Per Share, Diluted 0.17 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 92.2M USD +12.7%
Inventory, Net 164M USD +10.5%
Assets, Current 474M USD -6.47%
Deferred Income Tax Assets, Net 6.3M USD +43.2%
Property, Plant and Equipment, Net 111M USD -9.71%
Operating Lease, Right-of-Use Asset 29.4M USD +1.03%
Intangible Assets, Net (Excluding Goodwill) 226M USD +1.62%
Goodwill 794M USD +4.17%
Other Assets, Noncurrent 16.7M USD -9.73%
Assets 1.66B USD -0.53%
Accounts Payable, Current 51.4M USD -21.4%
Accrued Liabilities, Current 79.5M USD +9.35%
Liabilities, Current 208M USD +29.7%
Deferred Income Tax Liabilities, Net 23.4M USD +7.34%
Operating Lease, Liability, Noncurrent 28.8M USD -6.8%
Other Liabilities, Noncurrent 10.5M USD -31.8%
Liabilities 436M USD +0.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -37.5M USD -32%
Retained Earnings (Accumulated Deficit) -314M USD +2.39%
Stockholders' Equity Attributable to Parent 1.22B USD -1.04%
Liabilities and Equity 1.66B USD -0.53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8M USD -17.6%
Net Cash Provided by (Used in) Financing Activities -700K USD +96.8%
Net Cash Provided by (Used in) Investing Activities -2M USD +50%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.9M USD +62.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 92.2M USD +12.7%
Deferred Tax Assets, Valuation Allowance 4.3M USD -52.2%
Deferred Tax Assets, Gross 57.7M USD -2.7%
Operating Lease, Liability 41.1M USD -7.64%
Depreciation 20.1M USD +17.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.4M USD +94.7%
Lessee, Operating Lease, Liability, to be Paid 48.2M USD -9.4%
Property, Plant and Equipment, Gross 240M USD +0.71%
Operating Lease, Liability, Current 14.4M USD +6.67%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.3M USD +1.09%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.5M USD +3.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.7M USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 10.3M USD -43.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.2M USD -10.1%
Additional Paid in Capital 1.67B USD +1%
Amortization of Intangible Assets 25.1M USD +5.46%
Depreciation, Depletion and Amortization 11.4M USD -5.79%
Deferred Tax Assets, Net of Valuation Allowance 53.4M USD +6.16%
Share-based Payment Arrangement, Expense 15.3M USD -4.38%
Interest Expense 14.6M USD +19.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%